Results 191 to 200 of about 402,235 (309)

Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR database

Arthritis &Rheumatology, Accepted Article.
Background The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasing immunosuppressive (IST) and anti‐fibrotic therapies available. However, their real‐world use remains unclear. Objectives To analyze treatment trends and the effect of IST and anti‐fibrotic therapies on ILD progression ...
Corrado Campochiaro, Marie‐Elise Truchetet, Madelon Vonk, Giacomo De Luca, Giovanna Cuomo, Lidia P. Ananieva, Eric Hachulla, Vanessa Smith, Ana Maria Gheorghiu, Radim Becvar, Patricia Carreira, Nicolas Hunzelmann, Daniel E. Furst, Vera Ortiz‐Santamaria, Francesco Del Galdo, Marco Matucci‐Cerinic, Anna‐Maria Hoffmann‐Vold, EUSTAR collaborators   +17 more
wiley   +1 more source

Premovement activity in the corticospinal tract is amplified by the placebo effect: an active inference account. [PDF]

Soc Cogn Affect Neurosci
Emadi Andani M, Braga M, Da Dalt F, Piedimonte A, Carlino E, Fiorio M.   +5 more
europepmc   +1 more source

Intra-articular placebo effect in the treatment of knee osteoarthritis: a survey of the current clinical evidence. [PDF]

Ther Adv Musculoskelet Dis, 2022
Fazeli MS, McIntyre L, Huang Y, Chevalier X.   +3 more
europepmc   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Risk of Autoimmune Rheumatic Diseases

Arthritis &Rheumatology, Accepted Article.
Objective GLP‐1 receptor agonists (GLP‐1RAs) and SGLT2 inhibitors (SGLT2is) facilitate weight loss and exhibit immunomodulatory effects, but their impact on the risk of developing autoimmune rheumatic diseases (ARDs) is unclear. We compared ARD incidence following initiation of GLP‐1RAs, or SGLT2is, vs.
Derin Karacabeyli, Diane Lacaille, Na Lu, Hui Xie, J. Antonio Aviña‐Zubieta   +4 more
wiley   +1 more source

The Effect of Ginger ( Zingiber Officinale Roscoe) and Turmeric ( Curcuma Longa ) Supplementation on 17-β Estradiol Level, Quality of Life and Body Composition in Postmenopausal Women: Secondary Outcomes of a Randomized, Placebo Controlled Trial

Seyed Kazem Shakouri, Yaghoub Salekzamani, Neda Dolatkhah, Sanam Dolati, Maryam Hashemian   +4 more
openalex   +1 more source

Measuring the Impact: MRI Response of Sacroiliac Joints to TNF Inhibitors in Youth with Axial Disease

Arthritis &Rheumatology, Accepted Article.
Objective To evaluate the timeline for resolution of sacroiliac joint (SIJ) inflammation, changes in structural lesions, and their correlation with patient‐reported outcomes in youth with axial juvenile spondyloarthritis (axJSpA) initiating TNF inhibitor (TNFi).
Timothy G. Brandon, Rui Xiao, Daniel J. Lovell, Edward Oberle, Matthew L. Stoll, Nancy A. Chauvin, Michael L. Francavilla, Walter P. Maksymowych, Pamela F. Weiss   +8 more
wiley   +1 more source

"Homeopathy is not placebo effect": proof of the scientific evidence for homeopathy. [PDF]

Rev Assoc Med Bras (1992)
Teixeira MZ.
europepmc   +1 more source

Effect of synbiotic in constipated adult women – A randomized, double-blind, placebo-controlled study of clinical response [PDF]

, 2012
Dan Linetzky Waitzberg, L. Logullo, Amanda F. Bittencourt, Raquel Susana Torrinhas, Glaucia M. Shiroma, Natalia P. Paulino, Maria L. Teixeira-da-Silva   +6 more
openalex   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source